The ABPI UK Pharma Reputation Index reveals that the public’s positive sentiment towards the pharmaceutical sector continues, with 67% acknowledging
Continue readingCategory: Pharma
Royalty Pharma secures up to $500 Million synthetic royalty deal for Ferring’s gene therapy adstiladrin
Royalty Pharma has secured a synthetic royalty deal with Ferring Pharmaceuticals for the gene therapy adstiladrin (nadofaragene firadenovec-vncg).
Continue readingGovernment launches Rs 5,000 Crore scheme to boost research in Pharmaceutical and Medtech innovation
The Indian government has unveiled a scheme focused on fostering research and innovation in the pharmaceutical and medical technology (medtech)
Continue readingNovo Nordisk to acquire Inversago Pharma for up to $1.08 Billion, expanding obesity drug portfolio
The Danish pharmaceutical company Novo Nordisk is set to acquire Inversago Pharma, a privately held obesity drug manufacturer, for a
Continue readingGrünenthal and Kyowa Kirin establish joint venture: Launching Grünenthal Meds for enhanced pain management portfolio
Grünenthal GmbH and Kyowa Kirin Co. have successfully formed a joint venture collaboration to create a new entity named Grünenthal
Continue readingStrong start to rebuilding year: Takeda Pharmaceutical beats analysts’ estimates with robust Q1 profit
Takeda Pharmaceutical, Japan’s major pharmaceutical company, surpassed analysts’ expectations with a strong first-quarter profit.
Continue readingGland Pharma shares surge over 8% as US FDA approves drug application
Gland Pharma Ltd., a pharmaceutical company, experienced a surge in its stock prices following the approval of its drug application
Continue readingOBS Group nearing acquisition of Bayer’s pharmaceutical assets in Pakistan
Pakistan’s OBS Group is in advanced talks to acquire pharmaceutical assets from Bayer AG in the country.
Continue readingTelix Pharmaceuticals hits all-time high as it acquires Lightpoint Medical
Telix Pharmaceuticals experienced a more than 3% increase in its stock price, reaching an all-time high, following its announcement of
Continue readingPAG invests $200 Million in RK Pharma Inc, boosting growth and innovation
RK Pharma Inc., a vertically integrated pharmaceutical company specialising in affordable generic pharmaceutical products, is set to receive a $200
Continue reading
English